Cargando…
Toxicities associated with checkpoint inhibitors—an overview
Immunotherapy has an increasing role in the management of cancer, both in metastatic disease and as an adjuvant therapy. However, sensitization of the immune system with checkpoint inhibitors comes with a unique side effect profile. Full appreciation of this can take some time to emerge as some adve...
Autores principales: | Spiers, Laura, Coupe, Nicholas, Payne, Miranda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900917/ https://www.ncbi.nlm.nih.gov/pubmed/31816085 http://dx.doi.org/10.1093/rheumatology/kez418 |
Ejemplares similares
-
Clinical characteristics of rheumatic syndromes associated with checkpoint inhibitors therapy
por: Kostine, Marie, et al.
Publicado: (2019) -
Frequency and distribution of various rheumatic disorders associated with checkpoint inhibitor therapy
por: Abdel-Wahab, Noha, et al.
Publicado: (2019) -
Impact of age on the toxicity of immune checkpoint inhibition
por: Samani, Amit, et al.
Publicado: (2020) -
Setting the scene – a future ‘epidemic’ of immune-related adverse events in association with checkpoint inhibitor therapy
por: Bermudez, Maria V, et al.
Publicado: (2019) -
Management of rheumatic complications of immune checkpoint inhibitor therapy – an oncological perspective
por: Steven, Neil M, et al.
Publicado: (2019)